PRK Stock Overview
Through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for PRK from our risk checks.
ProAssurance Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.20 |
| 52 Week High | US$16.60 |
| 52 Week Low | US$10.00 |
| Beta | 0.25 |
| 11 Month Change | 14.89% |
| 3 Month Change | 31.71% |
| 1 Year Change | 39.66% |
| 33 Year Change | -19.80% |
| 5 Year Change | -52.91% |
| Change since IPO | -23.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRK | DE Insurance | DE Market | |
|---|---|---|---|
| 7D | 1.3% | 1.8% | -0.02% |
| 1Y | 39.7% | 22.6% | 8.2% |
Return vs Industry: PRK exceeded the German Insurance industry which returned 22.4% over the past year.
Return vs Market: PRK exceeded the German Market which returned 7.4% over the past year.
Price Volatility
| PRK volatility | |
|---|---|
| PRK Average Weekly Movement | 5.6% |
| Insurance Industry Average Movement | 2.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PRK has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PRK's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 1,094 | Ned Rand | www.proassurance.com |
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
ProAssurance Corporation Fundamentals Summary
| PRK fundamental statistics | |
|---|---|
| Market cap | €813.03m |
| Earnings (TTM) | €41.25m |
| Revenue (TTM) | €1.11b |
19.8x
P/E Ratio0.7x
P/S RatioIs PRK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRK income statement (TTM) | |
|---|---|
| Revenue | US$1.16b |
| Cost of Revenue | US$886.57m |
| Gross Profit | US$273.69m |
| Other Expenses | US$230.74m |
| Earnings | US$42.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 23.59% |
| Net Profit Margin | 3.70% |
| Debt/Equity Ratio | 34.6% |
How did PRK perform over the long term?
See historical performance and comparison